Reader Robert used the website's "Contact Me" on 2023-1-16 to inquire:
"For right cervical pelvis 2.58CM, if gravel surgery is invalid, and he may be treated with general anesthesia (rated level 3 risk) 2-3 Time (Assessed by a doctor). Currently oral administration of the original Rowatinex Rowatinex in Germany, 4 times a day, one at a time. Is there any help? Thank you! Male 62 years old, 1.5CM left kidney pelvis in 104, 1.68CM right kidney pelvis in 105, 1.68CM outside the body shattered several external shock waves The stone ESWL has been effective and is now re-exploited! ”The ESWL mentioned by the reader is extracorporeal Shock wave lithotripsy is a treatment for kidney stones, while Rowatinex is a health supplement that sounds like helping to expel kidney stones (no doctor's prescription required).
Although all relevant websites in Taiwan say "German original Rowatinex", Rowatinex is actually produced by a company called Rowa Pharmaceuticals Ltd. in Irish. Please see https://rowex.ie/rowatinex/.
According to the information provided by the Rowa Pharmaceuticals Ltd website, the main ingredients of Rowatinex are Pinene, Camphene, cineol (eucao), fenchone (cumin ketone), borneol (borneol), and anethol (fennel).
Since these ingredients are all terpene, medical literature sometimes calls Rowatinex terpene combination.
Most medical papers believe that Rowatinex can help with stone removal, but some say they cannot. Below are all the relevant medical papers I have collected.
1987: The value of Rowatinex in the treatment of ureterolithiasis. Compared with the pussy set, Rowatinex set had a higher success rate (self-departed stone discharge and/or silencing and disappearance of urogram collection system) (52% and 78% respectively), although there was no statistical significance.
1992: Rowatinex for the treatment of ureterolithiasis. Compared with the consolation set, the total stone discharge rate of the Rowatinex set was significantly higher: 59% and 81% respectively.
2009: Effect of Rowatinex on calculate clearance after extracorporeal shock wave lithotripsy. Rowatinex has no significant impact on the clearance rate of kidney stones after external gravel gravel surgery. However, the stone discharge can be accelerated after 2 weeks, and there are no obvious adverse reactions.
2011: Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study. The tamsulosin drug appears to be effective in patients with distal urethrasis with dichotomy less than 10 mm. However, using Rowatinex does not appear to have any significant impact on the clearance of remote urethral stones.
2011: A special terpene combination (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: results of a placebo-controlled randomised controlled trial (Rowatinex Compared with the comfort agent, terpene remedies are an effective treatment method to eliminate gravel fragments produced by external shock wave gravel..
2013: Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis (saccharide analysis of ureterolithiasis). The total effect estimate from the homogeneity study showed that the autonomic discharge rate of urinary tract stones was significantly improved in patients treated with terpene-based multiple drugs compared with the placement/control group.
2014: The effect of terpene combination on ureter calculations expulsion after extracorporeal shock wave lithotripsy. Long-term use of Rowatinex for 4 weeks improves urinary tract stone excretion rate after pulsating gravel surgery.
2014: Application of rowatinex in the periodic period in the extracorporeal shock wave lithotripsy. Rowatinex has a positive impact on the final results of external shock grafting in the case of complex medical inclusion, showing that it reduces debris discharge time, reduces the main symptoms, and reduces debris incidence, as well as reduces comorbiduria and severe dysfunction.
2016: Plant-derived terpenes in treating patients with urolithiasis. Rowatinex's gift medicine increases the percentage of skeleton debris removal after pulsating gravel grafts and reduces pain intensity. Rowatinex reduces white blood urination, increases diuresis and stabilizes urine pH for 24 hours. Increasing and stabilizing urine pH in patients with oxalate and uric acid salt stones can reduce the risk of recovery after external impact grafting. No reports of erratic symptoms related to Rowatinex allow for long-term use of this agent in recurrence of trauma and post-mortem disorders of recurrence of trauma.
2017: A network meta-analysis on the beneficial effect of medical exhaustive therapy after extracorporeal shock wave lithotripsy. We used the newly introduced online saccharification method to re-evaluate the lithotrip effect of drugs such as tamsulosin, doxazosin, nifedipine, terazosin and rowatinex after grafting lithotripsy. In the 15-day visit results, the efficiency rankings were: doxazosin > tamsulosin > rowatinex > nifedipine > terazosin (88.6, 77.4, 58.6, 32.2, and 30.4 respectively). In the 45-day visit results, the time-effect rankings were: tamsulosin > nifedipine > rowatinex (69.4, 67.2, and 62.6 respectively). In the 90-day visit results, the efficiency rankings were: doxazosin > rowatinex > tamsulosin (84.1, 68.1, and 49.1, respectively). As mentioned above, doxazosin and tamsulosin are expected to become the first choice drugs to promote the discharge of urinary tract stone fragments after external grafting. doxazosin can improve long-term stone clearance, and tamsulosin may cause more accelerated stone removal.
Original text: Does Rowatinex help to discharge kidney stones?